313 related articles for article (PubMed ID: 17532206)
21. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
22. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
23. [Prospective clinical study on new cutaneous melanomas in the Vendée area].
Brisson C; Reynaud-Hautin C; Bure E; Chatal M; Hadet-Riegert M; Rafstedt P; Humeau S; Kerangueven J; Leroux E; Legroux J; Martin MP; Nogues M; Remond L; Ottavy N; Thebaud Y; Patarin M; Clement A; Proux M
Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1125-8. PubMed ID: 14724515
[TBL] [Abstract][Full Text] [Related]
24. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
25. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
de Vries E; Boniol M; Doré JF; Coebergh JW;
Eur J Cancer; 2004 May; 40(7):1045-52. PubMed ID: 15093581
[TBL] [Abstract][Full Text] [Related]
26. Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemisphere.
Salmon PJ; Chan WC; Griffin J; McKenzie R; Rademaker M
Australas J Dermatol; 2007 Nov; 48(4):208-16. PubMed ID: 17956477
[TBL] [Abstract][Full Text] [Related]
27. [Malignant melanoma in El Salvador. Study of 101 cases].
Hernández-Pérez E; Baños JE; Serpas de López RM
Med Cutan Ibero Lat Am; 1982; 10(4):217-24. PubMed ID: 6763654
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of melanoma in Puerto Rico, 1987-2002.
Valentín SM; Sánchez JL; Figueroa LD; Nazario CM
P R Health Sci J; 2007 Dec; 26(4):343-8. PubMed ID: 18246962
[TBL] [Abstract][Full Text] [Related]
29. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous melanoma in New Zealand: 2000-2004.
Liang JJ; Robinson E; Martin RC
ANZ J Surg; 2010 May; 80(5):312-6. PubMed ID: 20557503
[TBL] [Abstract][Full Text] [Related]
31. Thick malignant melanoma is a long-term problem.
Asquith PR; Barnett JM; Lockett BK
N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
[TBL] [Abstract][Full Text] [Related]
32. Melanoma epidemic across the millennium: time trends of cutaneous melanoma in Emilia-Romagna (Italy) from 1997 to 2004.
Pellacani G; Lo Scocco G; Vinceti M; Albertini G; Raccagni AA; Baldassari L; Catrani S; Donelli S; Ghetti P; Lanzoni A; Leardini M; Reggiani M; Santini M; Stanganelli I; Virgili A; Seidenari S
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):213-8. PubMed ID: 18211415
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous malignant melanoma in young adults under age 30.
Tamir G; Milo Y; Rothem A; Sulkes J; Hauben DJ
Isr J Med Sci; 1996 Dec; 32(12):1290-6. PubMed ID: 9007174
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous malignant melanoma: experience of the British Columbia Cancer Agency from 1972 to 1981.
Carmichael VE; Wilson KS
Can J Surg; 1992 Dec; 35(6):589-97. PubMed ID: 1458384
[TBL] [Abstract][Full Text] [Related]
35. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
[TBL] [Abstract][Full Text] [Related]
36. The incidence and thickness of cutaneous malignant melanoma in New Zealand 1994-2004.
Richardson A; Fletcher L; Sneyd M; Cox B; Reeder AI
N Z Med J; 2008 Aug; 121(1279):18-26. PubMed ID: 18709044
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982-2001.
Whiteman DC; Bray CA; Siskind V; Hole D; MacKie RM; Green AC
Cancer Causes Control; 2007 Jun; 18(5):485-91. PubMed ID: 17450418
[TBL] [Abstract][Full Text] [Related]
38. Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
Garbe C; Thiess S; Nürnberger F; Ehlers G; Albrecht G; Lindlar F; Bertz J
Acta Derm Venereol; 1991; 71(6):506-11. PubMed ID: 1685833
[TBL] [Abstract][Full Text] [Related]
39. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
[TBL] [Abstract][Full Text] [Related]
40. Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years.
Ragnarsson-Olding BK; Nilsson PJ; Olding LB; Nilsson BR
Acta Oncol; 2009; 48(1):125-31. PubMed ID: 18607861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
